Mechanistic Modeling of Antibody Drug Conjugate Pharmacokinetics

Antibody Drug Conjugates (ADCs) are constructed by attaching a small molecule drug to an antibody via a linker. The antibody selectively targets tumor cells and releases the cytotoxic drug within the cells to kill cancerous cells while sparing healthy tissue. Although some ADCs have been approved, many unanswered questions remain, such as drug-drug interactions (DDIs) and … Continued

1 of 1
Back to top
Powered by Translations.com GlobalLink OneLink Software